TreeWAS – Variant ID: rs28777

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
C44 Other malignant neoplasms of skin	1.000	0.000
C43-C44 Melanoma and other malignant neoplasms of skin	1.000	0.000
C43 Malignant melanoma of skin	0.998	0.002
C44.5 Skin of trunk	0.991	0.009
C44.3 Skin of other and unspecified parts of face	0.986	0.014
C43.5 Malignant melanoma of trunk	0.955	0.045
Chapter II Neoplasms	0.954	0.046
Chapter XII Diseases of the skin and subcutaneous tissue	0.954	0.046
# Top node	0.953	0.047
C44.1 Skin of eyelid, including canthus	0.952	0.048
L80-L99 Other disorders of the skin and subcutaneous tissue	0.950	0.050
C44.6 Skin of upper limb, including shoulder	0.950	0.050
Chapter V Mental and behavioural disorders	0.948	0.052
C44.2 Skin of ear and external auricular canal	0.940	0.060
C44.4 Skin of scalp and neck	0.938	0.062
Chapter IV Endocrine, nutritional and metabolic diseases	0.937	0.063
C43.7 Malignant melanoma of lower limb, including hip	0.930	0.070
C43.6 Malignant melanoma of upper limb, including shoulder	0.928	0.072
F00-F09 Organic, including symptomatic, mental disorders	0.928	0.072
L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified	0.919	0.081
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.915	0.085
C44.0 Skin of lip	0.911	0.089
E70-E90 Metabolic disorders	0.909	0.091
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.905	0.095
L98.9 Disorder of skin and subcutaneous tissue, unspecified	0.905	0.095
D50-D53 Nutritional anaemias	0.891	0.109
D00-D09 In situ neoplasms	0.883	0.117
C50-C50 Malignant neoplasm of breast	0.877	0.123
E10-E14 Diabetes mellitus	0.871	0.129
L57 Skin changes due to chronic exposure to nonionising radiation	0.868	0.132
F05 Delirium, not induced by alcohol and other psychoactive substances	0.866	0.134
D50 Iron deficiency anaemia	0.866	0.134
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.864	0.136
L82 Seborrhoeic keratosis	0.862	0.138
L90 Atrophic disorders of skin	0.849	0.151
D50.9 Iron deficiency anaemia, unspecified	0.845	0.155
L57.0 Actinic keratosis	0.834	0.166
L92 Granulomatous disorders of skin and subcutaneous tissue	0.831	0.168
C44.7 Skin of lower limb, including hip	0.828	0.172
F40-F48 Neurotic, stress-related and somatoform disorders	0.822	0.178
C50 Malignant neoplasm of breast	0.822	0.178
C43.9 Malignant melanoma of skin, unspecified	0.819	0.181
F10 Mental and behavioural disorders due to use of alcohol	0.819	0.181
E87 Other disorders of fluid, electrolyte and acid-base balance	0.812	0.188
F05.9 Delirium, unspecified	0.808	0.192
C43.4 Malignant melanoma of scalp and neck	0.808	0.192
L89 Decubitus ulcer	0.806	0.194
Chapter XX External causes of morbidity and mortality	0.806	0.194
F03 Unspecified dementia	0.806	0.194
L90.5 Scar conditions and fibrosis of skin	0.792	0.208
D04 Carcinoma in situ of skin	0.790	0.210
D37-D48 Neoplasms of uncertain or unknown behaviour	0.789	0.211
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.785	0.215
E86 Volume depletion	0.783	0.217
E10 Insulin-dependent diabetes mellitus	0.778	0.222
L85 Other epidermal thickening	0.774	0.226
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.768	0.232
Chapter VI Diseases of the nervous system	0.767	0.233
D03 Melanoma in situ	0.760	0.240
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.759	0.241
F10.3 Withdrawal state	0.755	0.245
C44.9 Malignant neoplasm of skin, unspecified	0.749	0.251
L50-L54 Urticaria and erythema	0.744	0.256
L10-L14 Bullous disorders	0.739	0.261
Chapter XXII Codes for special purposes	0.739	0.261
C43.1 Malignant melanoma of eyelid, including canthus	0.736	0.264
E65-E68 Obesity and other hyperalimentation	0.736	0.264
C50.9 Breast, unspecified	0.735	0.265
D07 Carcinoma in situ of other and unspecified genital organs	0.735	0.265
L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified	0.728	0.272
E83 Disorders of mineral metabolism	0.726	0.274
F10.2 Dependence syndrome	0.725	0.275
D09 Carcinoma in situ of other and unspecified sites	0.725	0.275
W00-W19 Falls	0.723	0.277
C43.0 Malignant melanoma of lip	0.721	0.279
L94 Other localised connective tissue disorders	0.719	0.280
L60-L75 Disorders of skin appendages	0.718	0.282
C44.8 Overlapping lesion of skin	0.717	0.283
E80 Disorders of porphyrin and bilirubin metabolism	0.716	0.284
C43.8 Overlapping malignant melanoma of skin	0.716	0.284
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.713	0.287
L98.4 Chronic ulcer of skin, not elsewhere classified	0.712	0.288
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.712	0.288
C50.8 Overlapping lesion of breast	0.708	0.292
E14 Unspecified diabetes mellitus	0.708	0.292
F02 Dementia in other diseases classified elsewhere	0.706	0.294
L95 Vasculitis limited to skin, not elsewhere classified	0.703	0.297
F80-F89 Disorders of psychological development	0.701	0.299
D51 Vitamin B12 deficiency anaemia	0.701	0.299
C43.3 Malignant melanoma of other and unspecified parts of face	0.701	0.299
F45 Somatoform disorders	0.700	0.300
C40-C41 Malignant neoplasms of bone and articular cartilage	0.696	0.304
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.695	0.304
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.695	0.304
E87.5 Hyperkalaemia	0.695	0.305
D80-D89 Certain disorders involving the immune mechanism	0.695	0.305
F01 Vascular dementia	0.692	0.308
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.690	0.310
C43.2 Malignant melanoma of ear and external auricular canal	0.688	0.312
E11 Non-insulin-dependent diabetes mellitus	0.688	0.312
Chapter VIII Diseases of the ear and mastoid process	0.686	0.314
F00 Dementia in Alzheimer's disease	0.685	0.314
F70-F79 Mental retardation	0.685	0.315
F10.0 Acute intoxication	0.683	0.317
E88 Other metabolic disorders	0.683	0.317
E87.2 Acidosis	0.682	0.318
L87 Transepidermal elimination disorders	0.681	0.319
L86 Keratoderma in diseases classified elsewhere	0.681	0.319
D52 Folate deficiency anaemia	0.680	0.320
L56 Other acute skin changes due to ultraviolet radiation	0.680	0.320
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.679	0.321
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.679	0.321
L88 Pyoderma gangrenosum	0.677	0.323
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.677	0.323
F09 Unspecified organic or symptomatic mental disorder	0.675	0.325
E50-E64 Other nutritional deficiencies	0.675	0.325
E20-E35 Disorders of other endocrine glands	0.675	0.325
L85.8 Other specified epidermal thickening	0.674	0.325
L98.1 Factitial dermatitis	0.674	0.326
L20-L30 Dermatitis and eczema	0.673	0.327
L98.2 Febrile neutrophilic dermatosis [Sweet]	0.670	0.329
Chapter XVI Certain conditions originating in the perinatal period	0.668	0.332
D55-D59 Haemolytic anaemias	0.668	0.332
L99 Other disorders of skin and subcutaneous tissue in diseases classified elsewhere	0.668	0.332
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.666	0.333
F11 Mental and behavioural disorders due to use of opioids	0.666	0.334
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.665	0.334
L92.3 Foreign body granuloma of skin and subcutaneous tissue	0.665	0.335
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.665	0.335
E10.9 Without complications	0.663	0.337
E72 Other disorders of amino-acid metabolism	0.662	0.338
L72 Follicular cysts of skin and subcutaneous tissue	0.662	0.338
F99-F99 Unspecified mental disorder	0.660	0.340
D03.3 Melanoma in situ of other and unspecified parts of face	0.659	0.340
L98.7 Excessive and redundant skin and subcutaneous tissue	0.659	0.341
L98.6 Other infiltrative disorders of skin and subcutaneous tissue	0.659	0.341
L98.3 Eosinophilic cellulitis [Wells]	0.659	0.341
F12 Mental and behavioural disorders due to use of cannabinoids	0.659	0.341
C50.1 Central portion of breast	0.658	0.342
C50.5 Lower-outer quadrant of breast	0.657	0.343
E77 Disorders of glycoprotein metabolism	0.656	0.344
F05.8 Other delirium	0.655	0.344
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.654	0.346
L58 Radiodermatitis	0.654	0.346
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.652	0.348
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.652	0.348
L98.5 Mucinosis of skin	0.652	0.348
F05.0 Delirium not superimposed on dementia, so described	0.652	0.348
E76 Disorders of glycosaminoglycan metabolism	0.652	0.348
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.652	0.348
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.652	0.348
D50.0 Iron deficiency anaemia secondary to blood loss (chronic)	0.652	0.348
C73 Malignant neoplasm of thyroid gland	0.651	0.349
D02 Carcinoma in situ of middle ear and respiratory system	0.650	0.350
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.649	0.350
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.649	0.351
E84 Cystic fibrosis	0.647	0.353
L59 Other disorders of skin and subcutaneous tissue related to radiation	0.647	0.353
E87.6 Hypokalaemia	0.647	0.353
C51-C58 Malignant neoplasms of female genital organs	0.647	0.353
L89.2 Stage III decubitus ulcer	0.647	0.353
E79 Disorders of purine and pyrimidine metabolism	0.646	0.354
C50.3 Lower-inner quadrant of breast	0.645	0.355
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.645	0.355
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.641	0.359
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.640	0.359
L83 Acanthosis nigricans	0.640	0.360
E70 Disorders of aromatic amino-acid metabolism	0.639	0.361
F43 Reaction to severe stress, and adjustment disorders	0.639	0.361
D45 Polycythaemia vera	0.638	0.362
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.637	0.362
L91 Hypertrophic disorders of skin	0.637	0.363
L97 Ulcer of lower limb, not elsewhere classified	0.637	0.363
E78.5 Hyperlipidaemia, unspecified	0.636	0.364
L89.9 Decubitus ulcer and pressure area, unspecified	0.635	0.365
L55 Sunburn	0.634	0.366
Y43 Primarily systemic agents	0.634	0.366
E73 Lactose intolerance	0.633	0.367
E10.4 With neurological complications	0.631	0.369
L57.4 Cutis laxa senilis	0.631	0.369
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.631	0.369
F20 Schizophrenia	0.630	0.370
G30-G32 Other degenerative diseases of the nervous system	0.629	0.371
D50.1 Sideropenic dysphagia	0.628	0.371
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.627	0.373
L80 Vitiligo	0.627	0.373
E12 Malnutrition-related diabetes mellitus	0.625	0.375
E85 Amyloidosis	0.623	0.376
L57.3 Poikiloderma of Civatte	0.622	0.378
L57.2 Cutis rhomboidalis nuchae	0.622	0.378
L57.1 Actinic reticuloid	0.622	0.378
D04.5 Skin of trunk	0.621	0.378
E13 Other specified diabetes mellitus	0.620	0.380
F18 Mental and behavioural disorders due to use of volatile solvents	0.619	0.380
F16 Mental and behavioural disorders due to use of hallucinogens	0.619	0.380
L90.8 Other atrophic disorders of skin	0.619	0.381
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.619	0.381
D01 Carcinoma in situ of other and unspecified digestive organs	0.619	0.381
D07.5 Prostate	0.619	0.381
D04.6 Skin of upper limb, including shoulder	0.619	0.381
F41 Other anxiety disorders	0.618	0.382
D53 Other nutritional anaemias	0.618	0.382
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.617	0.383
F05.1 Delirium superimposed on dementia	0.617	0.383
C50.6 Axillary tail of breast	0.617	0.383
E74 Other disorders of carbohydrate metabolism	0.616	0.384
D04.7 Skin of lower limb, including hip	0.616	0.384
Y44 Agents primarily affecting blood constituents	0.616	0.384
L90.9 Atrophic disorder of skin, unspecified	0.616	0.384
L93 Lupus erythematosus	0.615	0.385
D04.3 Skin of other and unspecified parts of face	0.614	0.386
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.614	0.386
G50-G59 Nerve, nerve root and plexus disorders	0.613	0.387
F45.8 Other somatoform disorders	0.612	0.388
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.611	0.389
F42 Obsessive-compulsive disorder	0.611	0.389
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.610	0.390
D50.8 Other iron deficiency anaemias	0.610	0.390
L90.6 Striae atrophicae	0.609	0.391
L90.4 Acrodermatitis chronica atrophicans	0.609	0.391
L90.3 Atrophoderma of Pasini and Pierini	0.609	0.391
L90.2 Anetoderma of Jadassohn-Pellizzari	0.609	0.391
L90.1 Anetoderma of Schweninger-Buzzi	0.609	0.391
D46 Myelodysplastic syndromes	0.608	0.392
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.605	0.394
L92.2 Granuloma faciale [eosinophilic granuloma of skin]	0.605	0.395
L57.5 Actinic granuloma	0.604	0.396
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.603	0.397
L00-L08 Infections of the skin and subcutaneous tissue	0.603	0.397
F60-F69 Disorders of adult personality and behaviour	0.602	0.397
L89.1 Stage II decubitus ulcer	0.602	0.398
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified	0.602	0.398
D60-D64 Aplastic and other anaemias	0.601	0.399
F10.4 Withdrawal state with delirium	0.601	0.399
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.600	0.400
V98-V99 Other and unspecified transport accidents	0.599	0.401
F44 Dissociative [conversion] disorders	0.599	0.401
L92.1 Necrobiosis lipoidica, not elsewhere classified	0.596	0.404
D09.0 Bladder	0.595	0.405
F14 Mental and behavioural disorders due to use of cocaine	0.595	0.405
L98.0 Pyogenic granuloma	0.594	0.406
F10.8 Other mental and behavioural disorders	0.593	0.407
E10.2 With renal complications	0.593	0.407
X00-X09 Exposure to smoke, fire and flames	0.591	0.408
L92.8 Other granulomatous disorders of skin and subcutaneous tissue	0.590	0.410
X30-X39 Exposure to forces of nature	0.590	0.410
L89.3 Stage IV decubitus ulcer	0.590	0.410
Y10-Y34 Event of undetermined intent	0.589	0.411
C75 Malignant neoplasm of other endocrine glands and related structures	0.587	0.412
L50 Urticaria	0.587	0.413
L72.9 Follicular cyst of skin and subcutaneous tissue, unspecified	0.586	0.414
F10.6 Amnesic syndrome	0.586	0.414
D70-D77 Other diseases of blood and blood-forming organs	0.585	0.415
Y57 Other and unspecified drugs and medicaments	0.584	0.415
V70-V79 Bus occupant injured in transport accident	0.584	0.415
V01-V09 Pedestrian injured in transport accident	0.584	0.416
V95-V97 Air and space transport accidents	0.583	0.417
Y48 Anaesthetics and therapeutic gases	0.583	0.417
D04.1 Skin of eyelid, including canthus	0.583	0.417
D04.9 Skin, unspecified	0.582	0.417
E87.4 Mixed disorder of acid-base balance	0.582	0.418
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.582	0.418
G00-G09 Inflammatory diseases of the central nervous system	0.581	0.419
X58-X59 Accidental exposure to other and unspecified factors	0.581	0.419
W75-W84 Other accidental threats to breathing	0.581	0.419
D03.4 Melanoma in situ of scalp and neck	0.580	0.420
V10-V19 Pedal cyclist injured in transport accident	0.579	0.421
X10-X19 Contact with heat and hot substances	0.579	0.421
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.579	0.421
E83.3 Disorders of phosphorus metabolism	0.579	0.421
Y35-Y36 Legal intervention and operations of war	0.578	0.422
X85-X99 Assault	0.578	0.422
W65-W74 Accidental drowning and submersion	0.578	0.422
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.578	0.422
E66 Obesity	0.578	0.422
D03.7 Melanoma in situ of lower limb, including hip	0.577	0.423
L29 Pruritus	0.577	0.423
E78.9 Disorder of lipoprotein metabolism, unspecified	0.576	0.423
Y41 Other systemic anti-infectives and antiparasitics	0.576	0.424
V90-V94 Water transport accidents	0.576	0.424
X20-X29 Contact with venomous animals and plants	0.575	0.425
L89.0 Stage I decubitus ulcer and pressure area	0.575	0.425
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency	0.575	0.425
G20-G26 Extrapyramidal and movement disorders	0.575	0.425
E83.1 Disorders of iron metabolism	0.575	0.425
F48 Other neurotic disorders	0.574	0.425
V40-V49 Car occupant injured in transport accident	0.574	0.425
D04.2 Skin of ear and external auricular canal	0.573	0.427
Y60-Y69 Misadventures to patients during surgical and medical care	0.572	0.428
D04.0 Skin of lip	0.572	0.428
G80-G83 Cerebral palsy and other paralytic syndromes	0.571	0.429
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.570	0.430
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.570	0.430
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.569	0.431
L53 Other erythematous conditions	0.569	0.431
E10.3 With ophthalmic complications	0.569	0.431
E40-E46 Malnutrition	0.568	0.432
X50-X57 Overexertion, travel and privation	0.567	0.433
D04.8 Skin of other sites	0.567	0.433
W10 Fall on and from stairs and steps	0.566	0.433
E10.5 With peripheral circulatory complications	0.566	0.434
E10.7 With multiple complications	0.566	0.434
E10.8 With unspecified complications	0.566	0.434
E87.0 Hyperosmolality and hypernatraemia	0.566	0.434
G90-G99 Other disorders of the nervous system	0.566	0.434
W50-W64 Exposure to animate mechanical forces	0.565	0.435
W13 Fall from, out of or through building or structure	0.564	0.436
Y53 Agents primarily affecting the gastro-intestinal system	0.564	0.436
Chapter I Certain infectious and parasitic diseases	0.564	0.436
D03.2 Melanoma in situ of ear and external auricular canal	0.564	0.436
E10.1 With ketoacidosis	0.562	0.438
F06.7 Mild cognitive disorder	0.562	0.438
E10.6 With other specified complications	0.561	0.439
L12 Pemphigoid	0.561	0.439
D06 Carcinoma in situ of cervix uteri	0.561	0.439
D04.4 Skin of scalp and neck	0.561	0.439
Y58 Bacterial vaccines	0.560	0.440
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.560	0.440
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.560	0.440
F30-F39 Mood [affective] disorders	0.560	0.440
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.559	0.441
C74 Malignant neoplasm of adrenal gland	0.559	0.441
Y46 Antiepileptics and anti-Parkinsonism drugs	0.559	0.441
W18 Other fall on same level	0.559	0.441
E87.3 Alkalosis	0.558	0.441
E83.4 Disorders of magnesium metabolism	0.558	0.442
H80-H83 Diseases of inner ear	0.558	0.442
F40 Phobic anxiety disorders	0.557	0.443
F81 Specific developmental disorders of scholastic skills	0.556	0.444
F23 Acute and transient psychotic disorders	0.555	0.445
L85.3 Xerosis cutis	0.555	0.445
L85.2 Keratosis punctata (palmaris et plantaris)	0.555	0.445
L85.0 Acquired ichthyosis	0.555	0.445
F10.9 Unspecified mental and behavioural disorder	0.555	0.445
L11 Other acantholytic disorders	0.554	0.446
L92.0 Granuloma annulare	0.554	0.446
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.554	0.446
Y49 Psychotropic drugs, not elsewhere classified	0.553	0.446
V80-V89 Other land transport accidents	0.553	0.447
D03.1 Melanoma in situ of eyelid, including canthus	0.553	0.447
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.553	0.447
Y47 Sedatives, hypnotics and antianxiety drugs	0.552	0.448
L13 Other bullous disorders	0.552	0.448
L85.1 Acquired keratosis [keratoderma] palmaris et plantaris	0.552	0.448
V20-V29 Motorcycle rider injured in transport accident	0.552	0.448
E14.3 With ophthalmic complications	0.551	0.449
W20-W49 Exposure to inanimate mechanical forces	0.550	0.450
D07.4 Penis	0.550	0.450
F10.7 Residual and late-onset psychotic disorder	0.550	0.450
W19 Unspecified fall	0.550	0.450
D03.0 Melanoma in situ of lip	0.550	0.450
F21 Schizotypal disorder	0.550	0.450
F10.1 Harmful use	0.549	0.451
E78.8 Other disorders of lipoprotein metabolism	0.547	0.453
E87.7 Fluid overload	0.547	0.453
E65 Localised adiposity	0.546	0.453
D03.5 Melanoma in situ of trunk	0.546	0.454
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.546	0.454
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.546	0.454
D03.9 Melanoma in situ, unspecified	0.545	0.455
E80.4 Gilbert's syndrome	0.545	0.455
F22 Persistent delusional disorders	0.545	0.455
Y42.5 Other oestrogens and progestogens	0.545	0.455
F28 Other nonorganic psychotic disorders	0.544	0.455
F24 Induced delusional disorder	0.544	0.455
G70-G73 Diseases of myoneural junction and muscle	0.543	0.456
W07 Fall involving chair	0.543	0.457
E87.1 Hypo-osmolality and hyponatraemia	0.541	0.458
Q50-Q56 Congenital malformations of genital organs	0.540	0.460
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.540	0.460
E11.0 With coma	0.540	0.460
Y50 Central nervous system stimulants, not elsewhere classified	0.538	0.461
Q80-Q89 Other congenital malformations	0.538	0.462
W08 Fall involving other furniture	0.538	0.462
H90-H95 Other disorders of ear	0.537	0.463
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.537	0.463
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.537	0.463
W03 Other fall on same level due to collision with, or pushing by, another person	0.536	0.463
F25 Schizoaffective disorders	0.536	0.464
E89.0 Postprocedural hypothyroidism	0.536	0.464
Y59 Other and unspecified vaccines and biological substances	0.536	0.464
E89.3 Postprocedural hypopituitarism	0.535	0.465
W05 Fall involving wheelchair	0.534	0.466
D09.1 Other and unspecified urinary organs	0.534	0.466
L54 Erythema in diseases classified elsewhere	0.534	0.466
C50.0 Nipple and areola	0.533	0.466
L94.9 Localised connective tissue disorder, unspecified	0.533	0.467
W00 Fall on same level involving ice and snow	0.533	0.467
E78.2 Mixed hyperlipidaemia	0.533	0.467
D07.0 Endometrium	0.532	0.468
E11.5 With peripheral circulatory complications	0.532	0.468
D07.3 Other and unspecified female genital organs	0.531	0.469
F02.0 Dementia in Pick's disease	0.531	0.469
W01 Fall on same level from slipping, tripping and stumbling	0.531	0.469
X40-X49 Accidental poisoning by and exposure to noxious substances	0.531	0.469
E11.4 With neurological complications	0.530	0.470
L40-L45 Papulosquamous disorders	0.530	0.470
E66.9 Obesity, unspecified	0.530	0.470
L14 Bullous disorders in diseases classified elsewhere	0.530	0.470
D07.2 Vagina	0.530	0.470
D03.8 Melanoma in situ of other sites	0.529	0.470
D52.9 Folate deficiency anaemia, unspecified	0.529	0.471
E80.6 Other disorders of bilirubin metabolism	0.529	0.471
W17 Other fall from one level to another	0.529	0.471
L94.2 Calcinosis cutis	0.528	0.472
E67 Other hyperalimentation	0.528	0.472
E68 Sequelae of hyperalimentation	0.528	0.472
D09.9 Carcinoma in situ, unspecified	0.527	0.472
W15 Fall from cliff	0.527	0.472
E11.2 With renal complications	0.527	0.473
E83.9 Disorder of mineral metabolism, unspecified	0.527	0.473
F29 Unspecified nonorganic psychosis	0.527	0.473
D07.6 Other and unspecified male genital organs	0.527	0.473
E27 Other disorders of adrenal gland	0.527	0.473
E80.2 Other porphyria	0.526	0.474
L94.8 Other specified localised connective tissue disorders	0.526	0.474
G50 Disorders of trigeminal nerve	0.526	0.474
L68 Hypertrichosis	0.525	0.475
F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease	0.525	0.475
D09.7 Carcinoma in situ of other specified sites	0.525	0.475
E14.4 With neurological complications	0.525	0.475
E14.8 With unspecified complications	0.524	0.476
F00.9 Dementia in Alzheimer's disease, unspecified	0.523	0.476
L90.0 Lichen sclerosus et atrophicus	0.522	0.477
D48.1 Connective and other soft tissue	0.522	0.477
Y42.7 Androgens and anabolic congeners	0.522	0.477
E80.1 Porphyria cutanea tarda	0.522	0.478
W16 Diving or jumping into water causing injury other than drowning or submersion	0.522	0.478
L95.9 Vasculitis limited to skin, unspecified	0.522	0.478
L84 Corns and callosities	0.522	0.478
L72.8 Other follicular cysts of skin and subcutaneous tissue	0.522	0.478
L52 Erythema nodosum	0.521	0.478
E14.1 With ketoacidosis	0.521	0.478
E83.8 Other disorders of mineral metabolism	0.520	0.480
E83.2 Disorders of zinc metabolism	0.520	0.480
E83.0 Disorders of copper metabolism	0.520	0.480
L94.3 Sclerodactyly	0.520	0.480
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.520	0.480
E14.5 With peripheral circulatory complications	0.520	0.480
D09.3 Thyroid and other endocrine glands	0.520	0.480
D09.2 Eye	0.520	0.480
F06.8 Other specified mental disorders due to brain damage and dysfunction and to physical disease	0.519	0.480
W06 Fall involving bed	0.519	0.481
C50.2 Upper-inner quadrant of breast	0.519	0.481
F02.3 Dementia in Parkinson's disease	0.519	0.481
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.519	0.481
E29 Testicular dysfunction	0.518	0.482
E80.7 Disorder of bilirubin metabolism, unspecified	0.518	0.482
W04 Fall while being carried or supported by other persons	0.518	0.482
Y40 Systemic antibiotics	0.517	0.482
E14.9 Without complications	0.517	0.483
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.517	0.483
E78.3 Hyperchylomicronaemia	0.517	0.483
F06.3 Organic mood [affective] disorders	0.517	0.483
L94.6 Ainhum	0.516	0.484
L94.5 Poikiloderma vasculare atrophicans	0.516	0.484
L94.4 Gottron's papules	0.516	0.484
L94.1 Linear scleroderma	0.516	0.484
L72.0 Epidermal cyst	0.516	0.484
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.515	0.484
L51 Erythema multiforme	0.515	0.484
L72.1 Trichilemmal cyst	0.515	0.485
L29.0 Pruritus ani	0.515	0.485
F01.9 Vascular dementia, unspecified	0.515	0.485
L75 Apocrine sweat disorders	0.515	0.485
L74 Eccrine sweat disorders	0.515	0.485
L67 Hair colour and hair shaft abnormalities	0.515	0.485
L64 Androgenic alopecia	0.515	0.485
L62 Nail disorders in diseases classified elsewhere	0.515	0.485
W11 Fall on and from ladder	0.515	0.485
F07.2 Postconcussional syndrome	0.515	0.485
Y00-Y09 Assault	0.514	0.486
E80.5 Crigler-Najjar syndrome	0.513	0.486
E80.3 Defects of catalase and peroxydase	0.513	0.486
E80.0 Hereditary erythropoietic porphyria	0.513	0.486
W09 Fall involving playground equipment	0.513	0.487
L94.0 Localised scleroderma [morphea]	0.513	0.487
E89.4 Postprocedural ovarian failure	0.513	0.487
F45.2 Hypochondriacal disorder	0.512	0.487
E11.8 With unspecified complications	0.512	0.488
D48.5 Skin	0.512	0.488
E14.0 With coma	0.512	0.488
L10 Pemphigus	0.512	0.488
D86 Sarcoidosis	0.512	0.488
D80 Immunodeficiency with predominantly antibody defects	0.511	0.489
F06.6 Organic emotionally labile [asthenic] disorder	0.511	0.489
F06.5 Organic dissociative disorder	0.511	0.489
F06.4 Organic anxiety disorder	0.511	0.489
F06.1 Organic catatonic disorder	0.511	0.489
F06.0 Organic hallucinosis	0.511	0.489
C45 Mesothelioma	0.511	0.489
F02.8 Dementia in other specified diseases classified elsewhere	0.511	0.489
D83 Common variable immunodeficiency	0.511	0.489
F45.3 Somatoform autonomic dysfunction	0.510	0.489
F45.4 Persistent somatoform pain disorder	0.510	0.489
F07.0 Organic personality disorder	0.510	0.490
D68 Other coagulation defects	0.510	0.490
L98.8 Other specified disorders of skin and subcutaneous tissue	0.509	0.491
D66 Hereditary factor VIII deficiency	0.509	0.491
E78.1 Pure hyperglyceridaemia	0.509	0.491

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations